News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,564 Results
Type
Article (1923)
Company Profile (3)
Press Release (68638)
Section
Business (21470)
Career Advice (9)
Deals (4552)
Drug Development (8160)
FDA (1804)
Job Trends (800)
News (37031)
Policy (3562)
Tag
Academia (93)
Allergies (6)
Alliances (8170)
ALS (7)
Alzheimer's disease (129)
Antibody-drug conjugate (ADC) (18)
Approvals (1839)
Artificial intelligence (17)
Automation (1)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (32)
Biotechnology (5)
Bladder cancer (15)
Brain cancer (2)
Breast cancer (29)
Cancer (291)
Cardiovascular disease (6)
Career advice (9)
CAR-T (6)
Cell therapy (32)
Clinical research (7133)
Collaboration (128)
Compensation (13)
Complete response letters (2)
COVID-19 (188)
C-suite (25)
Cystic fibrosis (4)
Data (290)
Depression (4)
Diabetes (20)
Diagnostics (604)
Digital health (1)
Drug discovery (17)
Duchenne muscular dystrophy (17)
Earnings (7706)
Events (7110)
Executive appointments (53)
FDA (1998)
Fibrodysplasia Ossificans Progressiva (1)
Funding (81)
Gene editing (3)
Generative AI (1)
Gene therapy (21)
GLP-1 (51)
Government (233)
Grass and pollen (1)
Guidances (17)
Healthcare (1077)
HIV (1)
Huntington's disease (1)
IgA nephropathy (8)
Immunology and inflammation (2)
Indications (5)
Infectious disease (195)
Inflammatory bowel disease (19)
Influenza (7)
Intellectual property (19)
IPO (1631)
Job creations (241)
Job search strategy (9)
Layoffs (6)
Legal (953)
Liver cancer (17)
Lung cancer (51)
Lymphoma (19)
Manufacturing (36)
MASH (8)
Medical device (1127)
Medtech (1128)
Mergers & acquisitions (3035)
Metabolic disorders (49)
Multiple sclerosis (10)
NASH (1)
Neurodegenerative disease (7)
Neuroscience (191)
NextGen: Class of 2025 (219)
Non-profit (61)
Obesity (19)
Opinion (2)
Ovarian cancer (14)
Pain (5)
Pancreatic cancer (9)
Parkinson's disease (21)
Partnered (2)
Patents (28)
Patient recruitment (13)
People (4999)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1935)
Phase II (3001)
Phase III (2693)
Pipeline (176)
Policy (1)
Postmarket research (241)
Preclinical (674)
Press Release (2)
Prostate cancer (9)
Radiopharmaceuticals (22)
Rare diseases (33)
Real estate (601)
Regulatory (2638)
Reports (6)
Research institute (93)
RNA editing (1)
Schizophrenia (10)
Series A (18)
Series B (11)
Service/supplier (1)
Sickle cell disease (2)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (8)
Vaccines (26)
Venture capital (2)
Weight loss (2)
Women's health (1)
Date
Today (5)
Last 7 days (27)
Last 30 days (174)
Last 365 days (2727)
2025 (1455)
2024 (3253)
2023 (3814)
2022 (7013)
2021 (6372)
2020 (5872)
2019 (3867)
2018 (3013)
2017 (3562)
2016 (3176)
2015 (4030)
2014 (3020)
2013 (2604)
2012 (2775)
2011 (2903)
2010 (2663)
Location
Africa (81)
Alabama (3)
Arizona (9)
Asia (21559)
Australia (2440)
California (428)
Canada (263)
China (223)
Colorado (4)
Connecticut (17)
Delaware (4)
Europe (12611)
Florida (38)
Georgia (9)
Illinois (22)
India (11)
Indiana (6)
Japan (117)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (83)
Massachusetts (297)
Michigan (3)
Minnesota (29)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (248)
New York (176)
North Carolina (66)
Northern California (162)
Ohio (3)
Oregon (1)
Pennsylvania (71)
South America (107)
Southern California (199)
Tennessee (1)
Texas (39)
United States (1615)
Utah (13)
Virginia (32)
Washington D.C. (3)
Washington State (20)
Wisconsin (6)
70,564 Results for "evogene ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Evogene Reports First Quarter 2024 Financial Results
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter period ended March 31, 2024.
May 23, 2024
·
18 min read
Business
Evogene Schedules First Quarter 2024 Financial Results Release
Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development, announced that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024.
May 9, 2024
·
2 min read
Business
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Evogene Ltd. today announced its financial results for the fourth quarter and full-year period ending December 31, 2023.
March 7, 2024
·
19 min read
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Business
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Evogene Ltd announced today that it will release its financial results for the third quarter of 2023 on Thursday, March 7th, 2024.
February 26, 2024
·
2 min read
Business
Evogene Reports Third Quarter 2023 Financial Results
Evogene Ltd today announced its financial results for the third quarter period ended September 30, 2023.
November 15, 2023
·
18 min read
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - March 20, 2024
Evogene Ltd. reported that the Company received a letter from the Nasdaq Stock Market LLC, indicating that the Company is currently not in compliance with Nasdaq Rule 5550, as the Company’s closing bid price for its ordinary shares has been below $1.00 per share for the last 30 consecutive business days.
March 20, 2024
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Business
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
Evogene Ltd. announced that it will release its financial results for the third quarter of 2023, on Wednesday, November 15, 2023.
November 2, 2023
·
2 min read
Business
Evogene Reports Second Quarter 2023 Financial Results
Evogene Ltd. today announced its financial results for the second quarter period ended June 30, 2023.
August 17, 2023
·
18 min read
1 of 7,057
Next
